These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17541739)

  • 1. Melatonin, environmental light, and breast cancer.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Esquifino AI; Cardinali DP; Maestroni GJ
    Breast Cancer Res Treat; 2008 Apr; 108(3):339-50. PubMed ID: 17541739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.
    Blask DE; Dauchy RT; Brainard GC; Hanifin JP
    Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
    Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
    Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue.
    Pauley SM
    Med Hypotheses; 2004; 63(4):588-96. PubMed ID: 15325001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
    Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
    J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial lighting in the industrialized world: circadian disruption and breast cancer.
    Stevens RG
    Cancer Causes Control; 2006 May; 17(4):501-7. PubMed ID: 16596303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle.
    Davis S; Mirick DK
    Cancer Causes Control; 2006 May; 17(4):539-45. PubMed ID: 16596308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light exposure at night, urinary 6-sulfatoxymelatonin, and serum estrogens and androgens in postmenopausal Japanese women.
    Nagata C; Nagao Y; Yamamoto S; Shibuya C; Kashiki Y; Shimizu H
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1418-23. PubMed ID: 18559557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
    Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
    J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin, sleep disturbance and cancer risk.
    Blask DE
    Sleep Med Rev; 2009 Aug; 13(4):257-64. PubMed ID: 19095474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are some melanomas caused by artificial light?
    Kvaskoff M; Weinstein P
    Med Hypotheses; 2010 Sep; 75(3):305-11. PubMed ID: 20347530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-tumor activity of pineal melatonin and cancer enhancing life styles in industrialized societies.
    Bartsch C; Bartsch H
    Cancer Causes Control; 2006 May; 17(4):559-71. PubMed ID: 16596311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark.
    Hansen J
    Cancer Causes Control; 2006 May; 17(4):531-7. PubMed ID: 16596307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin-estrogen interactions in breast cancer.
    Sánchez-Barceló EJ; Cos S; Mediavilla D; Martínez-Campa C; González A; Alonso-González C
    J Pineal Res; 2005 May; 38(4):217-22. PubMed ID: 15813897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin and mammary pathological growth.
    Cos S; Sánchez-Barceló EJ
    Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shift work, light at night, and breast cancer on Long Island, New York.
    O'Leary ES; Schoenfeld ER; Stevens RG; Kabat GC; Henderson K; Grimson R; Gammon MD; Leske MC;
    Am J Epidemiol; 2006 Aug; 164(4):358-66. PubMed ID: 16777931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibitor-induced joint pain: melatonin's role.
    Burk R
    Med Hypotheses; 2008 Dec; 71(6):862-7. PubMed ID: 18782656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.
    Santen R; Cavalieri E; Rogan E; Russo J; Guttenplan J; Ingle J; Yue W
    Ann N Y Acad Sci; 2009 Feb; 1155():132-40. PubMed ID: 19250200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.
    Cucina A; Proietti S; D'Anselmi F; Coluccia P; Dinicola S; Frati L; Bizzarri M
    J Pineal Res; 2009 Mar; 46(2):172-80. PubMed ID: 19175854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.